Nika Pharmaceuticals Inc.
NIKA · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $518,214 | – | – | – |
| - Cash | $2 | $20 | $1 | $0 |
| + Debt | $239 | $0 | $0 | $14 |
| Enterprise Value | $518,451 | – | – | – |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$96 | -$65 | -$3,184 | -$15 |
| % Margin | – | – | – | – |
| Net Income | -$96 | -$65 | -$3,184 | -$15 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0 | -0.004 | 0 |
| % Growth | 0% | 97.2% | – | – |
| Operating Cash Flow | -$139 | -$65 | -$34 | -$15 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$139 | -$65 | -$34 | -$15 |